Hamelin Paul 4
4 · SAVIENT PHARMACEUTICALS INC · Filed Feb 17, 2010
Insider Transaction Report
Form 4
Hamelin Paul
President
Transactions
- Sale
Common Stock, $.01 par value per share
2010-02-16$13.80/sh−1,433$19,774→ 88,441 total - Sale
Common Stock, $.01 par value per share
2010-02-16$13.80/sh−5,492$75,774→ 82,949 total
Footnotes (2)
- [F1]These shares were sold automatically pursuant to a binding contract under Rule 10b5-1 of the Securities Exchange Act of 1934, to cover tax withholding obligations in connection with the vesting of restricted stock granted on February 15, 2007.
- [F2]These shares were sold automatically pursuant to a binding contract under Rule 10b5-1 of the Securities Exchange Act of 1934, to cover tax withholding obligations in connection with the vesting of restricted stock granted on February 13, 2009.